Clinical Study to Evaluate Effect on QT/QTc Interval After Multiple Dose of Celecoxib

Inclusion Criteria: * Healthy adults between 19-year-old and 40-year-old during the screening day * BMI between 19 kg/m² and 30 kg/m² during the screening day * Be able to give an informed consent form after understanding for reasonable explanation of clinical trial's purpose, contents and characteristics of clinical drugs * Wiling to participate whole clinical trial periods Exclusion Criteria: * Person who is able to clinically affect to the study through ECG result during the screening day * Has critical issue for Torsade de points from heart failure, hypopotassemia, arrhythmia etc., or family history for long QT syndrome, sudden cardiac death. * Was suffered, or is suffering from like liver, kidney, digestive system, circulatory system, respiratory system, endocrine system(except diabetes), musculoskeletal, neuropsychiatry, or hemato-oncology etc., which is able to effect on clinical study * Has allergy which is required the treatment or hypersensitive from drugs such as aspirin, anti-biotics, anti-depressants, etc. * Was administered any drug of other clinical study within 90 days from the randomization day. * Donated whole blood within 60days or apheresis within 30 days from the randomization day. * Took any medicine or oriental medicine within 2 weeks, or general pharmaceuticals within 7 days from the randomization day. (For general pharmaceuticals circumstances, PI could decide whether he/she is suitable for the study) * No intention to take contraceptive which is a…